Read more about Why govt delayed emergency approval to coronavirus vaccine: Chidambaram on Business Standard. P Chidambaram accused the central government of needlessly delaying approval to Coronavirus vaccines in the country for many months except in the case of Covaxin, Covishield and Sputnik V
Why govt delayed emergency approval to Covid vax: Chidambaram
By IANS |
0 Views
Why govt delayed emergency approval to Covid vax: Chidambaram. Image Source: IANS News
New Delhi, June 3 : Congress leader and former Finance Minister P. Chidambaram on Thursday accused the central government of needlessly delaying approval to Coronavirus vaccines in the country for many months except in the case of Covaxin, Covishield and Sputnik V. Our suspicion that the government had not approved any vaccine other than Covishield, Covaxin and Sputnik V, has been proved correct, Chidambaram said. Why did government go through the charade of negotiating quantities with Pfizer and Moderna without first giving Emergency Use Approval (EUA) to their vaccines?
Social and environmental risk factors for dengue in Delhi city: A retrospective study
Olivier Telle , Roles Formal analysis, Writing – review & editing
Affiliation Mathematical Modelling of Infectious Diseases, Institut Pasteur, Centre National de la Recherche Scientifique, Paris, France ⨯
Vikram Kumar,
Samuel Benkimoun, Roles Methodology
BN Nagpal,
Affiliation National Institute of Malaria Research, Sector 8, Dwarka, Delhi, India ⨯
Richard E. Paul Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing
Affiliation Institut Pasteur, Functional Genetics of Infectious Diseases Unit, Paris, France
Olivier Telle,
Abstract
Global urbanization is leading to an inexorable spread of several major diseases that need to be stemmed.
URL copied
Tap water access in Delhi linked to dengue infection risk: Study
Tap water access in densely populated parts of Delhi is a strong predictor of the risk of contracting dengue, says a study that may lead to new strategies to control transmission of the deadly virus in urban areas. The dengue virus is among a growing number of mosquito-borne pathogens across the world that have adapted to spread in cities, the scientists, including Vikram Kumar from the National Institute of Malaria Research in Delhi, noted.
They said close to 3.5 billion people across the world are at risk of dengue viral infection which is spreading increasingly with growing rates of urbanisation. In the current study, published in the journal PLOS Neglected Tropical Diseases, the scientists analysed social and environmental risk factors for contracting the virus in Delhi.